Claim of unjust enrichment arising from facts alleging misappropriation of trade secrets was preempted by the Delaware Uniform Trade Secret Act, which displaced all claims providing a remedy of restitution.

Defendant was judicially estopped from asserting a position that was inconsistent with one taken in prior litigation.

Lump sum adjustment from Centers for Medicare and Medicaid Services received by debtors constituted a "settlement" and therefore qualified as a purchased asset that debtors were required to turn over under the terms of the parties' asset purchase agreement.

A temporary committee created by a company's board of directors did not have authority to terminate a lawsuit that was filed by an earlier special committee.